Sinovac Biotech Ltd. (SVA) Investigated by Block & Leviton LLP For Securities Fraud After Revelation Of SEC Inquiry; Shareholders Suffering Losses Are Encouraged To Contact The Firm
BOSTON, May 18, 2017 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA) and certain of its officers and directors violated federal securities laws following the revelation of an SEC investigation.
On December 21, 2016, the investor website Seeking Alpha published an article revealing that court documents demonstrate Sinovac's Chairman and CEO, Weidong Ying, bribed a member of the Chinese food and drug administration to help obtain approval for its drug.
Then, on May 16, 2017, Sinovac disclosed that the Company is under investigation by the SEC regarding Ying's bribery of officials and that the Company would not be able to timely file its annual financial results.
On this news, the Company's stock has fallen 5%, causing millions in losses to investors.
If you purchased or otherwise acquired Sinovac securities and have questions about your legal rights or possess information relevant to this investigation, you are encouraged to contact attorney Bradley Vettraino at (617) 398-5600, by email at [email protected], or by visiting www.blockesq.com/sinovac.
Confidentiality to whistleblowers or others with information relevant to this investigation is assured.
Block & Leviton LLP is a Boston-based law firm representing investors nationwide. The firm's lawyers have collectively been prosecuting securities cases on behalf of individual and institutional investors for over 50 years, and have recovered billions of dollars on their behalf. Block & Leviton's investigations into corporate wrongdoing were recently covered by the New York Times.
This notice may constitute attorney advertising.
CONTACT:
Block & Leviton LLP
Bradley J. Vettraino
155 Federal Street, Suite 400
Boston, MA 02110
(617) 398-5600
[email protected]
SOURCE Block & Leviton LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article